Wednesday, October 14, 2015 12:45:27 PM
Director of Molecular Therapeutics
Dr. Christine Ichim serves as Director of Molecular Therapeutics at Regen BioPharma, heading the DifferonC, Cancer Stem Cell, and Telomerase modulation programs. Dr. Ichim discovered the essential role of NR2F6 in maintaining cancer pathogenesis and that suppressing this therapeutic target results in cancer cells turning to normal cells. Dr. Ichim has authored 7 peer reviewed publications, made more than 21 presentations at international symposiums, and is inventor / co-inventor of 6 patent applications.
Dr. Christine Ichim completed a Masters of Science in the Department of Medical Biophysics at the University of Toronto with Dr. Norman Iscove, a pioneer in the stem cell field. In his lab she studied the cancer stem cell and identified genes that controlled the ability of leukemia cells to divide without exhaustion.
Dr. Ichim continued to decipher the genes that controlled the ability of cancer stem cells to divide indefinitely during her PhD in the Department of Medical Biophysics at the University of Toronto in the laboratory of Dr. Richard Wells, Co-director of the Myelodysplastic Syndromes Program, at Sunnybrook Health Science Center, a University of Toronto affiliated hospital. In his lab she established the function of the novel oncogene NR2F6.
She then completed post-doctoral training in the laboratory of Jan Karlseder at the Salk Institute for Biological Sciences where she continued to research the ability of cells to divide without exhaustion from the vantage point of telomere biology and genomic organization. This work was funded by Canadian Institutes of Health Research as a result of Dr. Ichim being awarded the Prize of Excellence in Research on Aging!!
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM